CLINICAL_TRIALS
trial_result
· 2010-11-01
Clinical Trial Update: Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet [Phase 4]
Summary
Abbott's Humira (adalimumab) completed a Phase 4, controlled trial in chronic plaque psoriasis of the hands and/or feet, with results posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abbott | Conditions: Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2010-11-01